Innovator Resources/VALUE_OF_YOUR_EQUITY_Logo_Hero.png
Your time is your most valuable asset. Invest it wisely.

If you are looking forward to a career in biotech, then you are an investor. Sound strange? Not at all - time is money, you are investing your time in a company, and they will pay you in both cash and equity. Ten thousand shares of one company could be worth much more than 30,000 shares of another company, but to know when that’s true, you need to know what questions to ask. Learn to evaluate competing job offers through the lens of an Equity Value Proposition (EVP). (Or if you're a company looking to hire top talent, learn how to craft a compelling EVP of your own!)

"Equity isn’t everything, but it’s important enough that every employee should know how to value it. If employees understood how to compare competing equity offers, some would likely make different decisions."

- Peter Kolchinsky, PhD, founder and Managing Partner at RA Capital Management

Understanding the Value of Your Equity

For the full experience, read through the complete deck. Or, work through these concepts one by one by exploring individual modules.

View presentation

Reach Out

Have questions about crafting your company's Equity Value Proposition? Members of the RA Capital team are happy to strategize with you. To learn more, contact a senior member of the RA Capital team.

Terms and Conditions


Before accessing these resources, the reader must review and acknowledge the following terms and conditions

By clicking “I Agree”, you acknowledge the following terms and conditions.

Publications are provided for informational purposes only and do not constitute an offer to sell, a solicitation to buy, or a recommendation for any security, nor do they constitute an offer or endorsement of RA Capital Management ("RA Capital")'s investment advisory or other services by RA Capital. The content of the publications neither constitutes investment advice nor offers any opinion with respect to the suitability of any security. Accounts managed by RA Capital may invest in certain companies referenced in the publications; however, RA Capital makes no guarantees as to accuracy or completeness of views expressed in the publications. Views expressed in the publications are subject to change, and may have become unreliable for various reasons, including changes in market conditions or economic circumstances. Any disclosures as to RA Capital is subject to change and is only valid as of the date the statement was made. By accessing the publications, the reader agrees that he/she will not copy, reproduce, republish, upload, post, transmit, alter, or distribute the publications in any way that is inconsistent with the purposes for which they are offered, without the prior written consent of RA Capital.


This disclaimer is in addition to all disclaimers found on the RA Capital website.